EcoDrugPlus

Toll-Like Receptor 2 Type-1

Ensembl ID : ENSPREG00000006019
Gene Symbol: LOC103480941
2 Cross references
206 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSPREG00000019969
Gene Symbol: TAAR1
2 Cross references
348 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSPREG00000020037
Gene Symbol: TAAR1
3 Cross references
386 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSPREG00000019961
Gene Symbol: TAAR1
1 Cross references
417 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSPREG00000021967
Gene Symbol: LOC103480184
3 Cross references
199 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSPREG00000017933
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSPREG00000002705
Gene Symbol: LOC103462259
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSPREG00000013736
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSPREG00000011571
Gene Symbol: TUBA4A
2 Cross references
110 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSPREG00000015663
Gene Symbol: LOC103473792
2 Cross references
170 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSPREG00000022285
Gene Symbol: LOC103467815
2 Cross references
55 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSPREG00000008885
Gene Symbol: LOC103464382
2 Cross references
183 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).